✦ LIBER ✦

Bioavailability of intranasal formulations of dihydroergotamine

✍ Scribed by P-H. M. van der Kuy; J. J. H. M. Lohman; P. M. Hooymans; J. W. M. Ter Berg; F. W. H. M. Merkus

Publisher: Springer
Year: 1999
Tongue: English
Weight: 88 KB
Volume: 55
Category: Article
ISSN: 0031-6970
DOI: 10.1007/s002280050692

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Venoconstrictor effects of dihydroergota

Venoconstrictor effects of dihydroergotamine after intranasal and intramuscular administration

✍ W. H. Aellig; J. Rosenthaler 📂 Article 📅 1986 🏛 Springer 🌐 English ⚖ 320 KB

Bioavailability of dexmedetomidine after

Bioavailability of dexmedetomidine after intranasal administration

✍ Timo Iirola; Sanna Vilo; Tuula Manner; Riku Aantaa; Maria Lahtinen; Mika Scheini 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 267 KB

Bioavailability of atenolol formulations

✍ Dr. James McAinsh; Wilfred T. Simpson; Brian F. Holmes; Jean Young; Stuart H. El 📂 Article 📅 1980 🏛 John Wiley and Sons 🌐 English ⚖ 417 KB 👁 2 views

## Abstract In this comparative bioavailability study two tablet formulations of atenolol (sales and clinical trial) were compared with an oral solution. Twelve healthy adult male volunteers received, on a cross‐over basis, on three separate occasions, 100 mg oral dose of the three formulations of

Dihydroergotamine increases the bioavail

Dihydroergotamine increases the bioavailability of orally administered etilefrine

✍ J. H. Hengstmann; R. Hengstmann; S. Schwonzen; H. J. Dengler 📂 Article 📅 1982 🏛 Springer 🌐 English ⚖ 588 KB

Ciliotoxicity of intranasal formulations

Ciliotoxicity of intranasal formulations: Menthol enantiomers

✍ Xiang-Yao Su; Dr. Alain Li Wan Po; Jeffrey S. Millership 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 295 KB

Bioavailability of progesterone enhanced

Bioavailability of progesterone enhanced by intranasal spraying

✍ G. F. X. David; C. P. Puri; T. C. Anand Kumar 📂 Article 📅 1981 🏛 Springer 🌐 English ⚖ 238 KB